Journal of Neurology

Article	Citations
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)	215
The advances of post-stroke depression: 2021 update	140
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex	127
Neurological and cognitive sequelae of Covid-19: a four month follow-up	107
Rituximab for the treatment of multiple sclerosis: a review	102
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study	90
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials	89
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study	89
COVID-19 mRNA vaccination leading to CNS inflammation: a case series	78
Bell’s palsy following COVID-19 vaccination	71
Digital therapeutics in neurology	69
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation	66
Association of CNS demyelination and COVID-19 infection: an updated systematic review	66
Ischemic stroke associated with COVID-19: a systematic review and meta-analysis	63
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients	62
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms	61
Burden of disease in myasthenia gravis: taking the patient’s perspective	60
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up	59
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	58
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study	57
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review	56
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives	56
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung	56
Update on benign paroxysmal positional vertigo	55
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion	55

Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19	51
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential di	51
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature	50
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis	48
Neurological updates: neurological complications of CAR-T therapy	47
Alzheimer’s disease clinical trial update 2019–2021	46
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19	45
Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis	45
Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis	45
Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions	44
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines	43
Are some patient-perceived migraine triggers simply early manifestations of the attack?	42
Update cerebellum and cognition	42
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus	41
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses	41
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment	41
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients	39
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice	39
Wearables in the home-based assessment of abnormal movements in Parkinson’s disease: a systematic review of the literature	39
Migraine: from pathophysiology to treatment	39
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature	38
Fall prediction in neurological gait disorders: differential contributions from clinical assessment, gait analysis, and daily-life mobility monitoring	37
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients	37
Neuroimmune disorders in COVID-19	37
Central retina changes in Parkinson’s disease: a systematic review and meta-analysis	36
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocyto	36
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod	35
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2	35
Central positional nystagmus: an update	35
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review	34
Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis	34
The changing landscape of optic neuritis: a narrative review	34
Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses	33
Histopathology and high-resolution ultrasound imaging for peripheral nerve (injuries)	33
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review	33
Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review	33
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis	33
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)	33
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature	33
Outcome after surgical treatment of cerebrospinal fluid leaks in spontaneous intracranial hypotension—a matter of time	32
A rise in cases of nitrous oxide abuse: neurological complications and biological findings	32
Hearing loss versus vestibular loss as contributors to cognitive dysfunction	32
Repetitive transcranial magnetic stimulation for post-stroke depression: a randomised trial with neurophysiological insight	31
The relationship between body mass index and stroke: a systemic review and meta-analysis	31
Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives	31
A systematic review and meta-analysis of voxel-based morphometric studies of migraine	30
Neurological update: cognitive rehabilitation in multiple sclerosis	30
Nanoparticles for drug delivery in Parkinson’s disease	30
The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes	30
Acute vestibular syndrome: is skew deviation a central sign?	30

A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value	30
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension	30
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort	29
The trigeminal pathways	29
Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke	29
Glymphatic system dysfunction in patients with juvenile myoclonic epilepsy	29
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data	29
The natural history of primary progressive aphasia: beyond aphasia	29
Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder	28
Covid-19 and Parkinson’s disease: an overview	28
Consciously processing balance leads to distorted perceptions of instability in older adults	28
Functional motor phenotypes: to lump or to split?	28
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy	28
Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression	28
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome	28
Influence of heavy metals in Parkinson’s disease: an overview	28
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa	28
Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features	28
Capturing vertigo in the emergency room: three tools to double the rate of diagnosis	27
Most degenerative cervical myelopathy remains undiagnosed, particularly amongst the elderly: modelling the prevalence of degenerative cervical myelopathy in the United Kingdom	27
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort	27
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-ter	27
A systematic review of local field potential physiomarkers in Parkinson’s disease: from clinical correlations to adaptive deep brain stimulation algorithms	27
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis	27
Neurological update: COVID-19	27
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C	27
The inherited cerebellar ataxias: an update	26
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders	26
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience	26
Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	26
Neurological update: use of cardiac troponin in patients with stroke	26
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis	26
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease	26
Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative disease	25
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease	25
The INVEST trial: a randomised feasibility trial of psychologically informed vestibular rehabilitation versus current gold standard physiotherapy for people with Persistent Postural Perceptual Dizzine	25
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19	25
The sleep and circadian problems of Huntington’s disease: when, why and their importance	25
Sarcopenia and nervous system disorders	25
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients	25
Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review	24
Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients	24
Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis	24
A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials	24
Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2	24
Neuroimaging uncovers distinct relationships of glymphatic dysfunction and motor symptoms in Parkinson’s disease	24
Towards clinical application of implantable brain–computer interfaces for people with late-stage ALS: medical and ethical considerations	23
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective	23
A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis	23
Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients	23
Cognitive impairments are independently associated with shorter survival in diffuse glioma patients	23
Virtual reality balance training to improve balance and mobility in Parkinson’s disease: a systematic review and meta-analysis	23
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters	23
Long-term cognitive impairments following COVID-19: a possible impact of hypoxia	23
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap	23
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report	23
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis	22
Cerebrovascular manifestations in hematological diseases: an update	22
Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis	22
The complexities of CACNA1A in clinical neurogenetics	22
Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorder	22
Serum BDNF discriminates Parkinson’s disease patients with depression from without depression and reflect motor severity and gender differences	22
The “hype” of hydrops in classifying vestibular disorders: a narrative review	22
Cognitive impairment in temporal lobe epilepsy: contributions of lesion, localization and lateralization	22
Decreased aperiodic neural activity in Parkinson’s disease and dementia with Lewy bodies	22
Migraine in transient global amnesia: a meta-analysis of observational studies	22
Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry	21
Evidence for cognitive impairment in patients with vestibular disorders	21
Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19	21
Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study	21
Nitrous oxide-induced predominantly motor neuropathies: a follow-up study	21
MRI radiomic features-based machine learning approach to classify ischemic stroke onset time	21
COVID-19 severity is related to poor executive function in people with post-COVID conditions	21
Variants of the circle of Willis in ischemic stroke patients	21
Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis	21
Risk factors for migraine disease progression: a narrative review for a patient-centered approach	21
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease	21
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019	21
Characterization of gait variability in multiple system atrophy and Parkinson’s disease	21
Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus	21

How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update	21
Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies	21
Clinical, oculographic and vestibular test characteristics of Ménière’s disease	21
NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study	21
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients	20
Traumatic brain injury fast-forwards Alzheimer’s pathology: evidence from amyloid positron emission tomorgraphy imaging	20
Superficial siderosis of the central nervous system associated with ventral dural defects: bleeding from the epidural venous plexus	20
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?	20
The effect of exercise on cognitive function in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials	20
Preventing falls: the use of machine learning for the prediction of future falls in individuals without history of fall	20
Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?	20
RCVS: by clinicians for clinicians—a narrative review	20
MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation	20
Prognostic models for amyotrophic lateral sclerosis: a systematic review	20
Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study	20
New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts	19
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis	19
Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study	19
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations	19
Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)	19
Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis	19
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study	19
Characteristic differences between vestibular migraine and migraine only patients	19
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis	19
Guillain–Barré syndrome in patients treated with immune checkpoint inhibitors	19
Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients	18
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment	18
Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis	18
Time to onset and duration of botulinum toxin efficacy in movement disorders	18
Inter-method reliability of the modified Rankin Scale in patients with subarachnoid hemorrhage	18
An explanation for Terson syndrome at last: the glymphatic reflux theory	18
Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease	18
Are smartphones and machine learning enough to diagnose tremor?	18
Patients with multiple sclerosis: a burden and cost of illness study	18
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis	18
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity	18
Infratentorial pathology in frontotemporal dementia: cerebellar grey and white matter alterations in FTD phenotypes	18
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease	18
Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a comparison with balance and cognitive testing	18
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies	18
Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment	18
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience	18
Thrombolysis in central retinal artery occlusion: a retrospective observational study	18
Effects of a 12-week combined aerobic and strength training program in ambulatory patients with amyotrophic lateral sclerosis: a randomized controlled trial	17
Managing freezing of gait in Parkinson’s disease: a systematic review and network meta-analysis	17
Vestibular migraine or Meniere's disease: a diagnostic dilemma	17
Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies	17
Relationship between the degree of recanalization and functional outcome in acute ischemic stroke is mediated by penumbra salvage volume	17
Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment	17
COVID-19 manifestations in people with Parkinson’s disease: a USA cohort	17
Diagnosis and follow-up evaluation of central nervous system vasculitis: an evaluation of vessel-wall MRI findings	17
Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review	17
Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose–response meta-analysis	17
Wearable sensor-based gait analysis to discriminate early Parkinson’s disease from essential tremor	17
Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease	17
Brainstem clinical and neurophysiological involvement in COVID-19	17
The angiographic presentation of European Moyamoya angiopathy	17
COVID-19 in children with neuromuscular disorders	17
Efficacy of dance for Parkinson’s disease: a pooled analysis of 372 patients	17
Visual evoked potential latency predicts cognitive function in people with multiple sclerosis	17
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis	17
Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use	17
Pharmacological and non-pharmacological management of spinocerebellar ataxia: A systematic review	17
Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy	17
Detection of large vessel occlusion stroke with electroencephalography in the emergency room: first results of the ELECTRA-STROKE study	17
Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature	17
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis	17
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies	17
Clinical practice guidelines in idiopathic facial paralysis: systematic review using the appraisal of guidelines for research and evaluation (AGREE II) instrument	17
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease	16
Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia	16
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases	16
Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis	16
Triggers in functional motor disorder: a clinical feature distinct from precipitating factors	16
Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis	16
Altered brain network functional connectivity patterns in patients with vestibular migraine diagnosed according to the diagnostic criteria of the Bárány Society and the International Headache Society	16
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update	16
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications	16
Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study	16
Effect of transcranial direct current stimulation on post-stroke fatigue	16
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature	16
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study	16
Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study	16
Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction	16
Longitudinal cognitive and functional changes in primary progressive aphasia	16
Sneddon syndrome: a comprehensive clinical review of 53 patients	16
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors	16
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod	16
Adalimumab for CNS sarcoidosis: single-center experience and literature review	16
Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19	16
Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes	16
Evolution of caloric responses during and between the attacks of Meniere’s disease	15
Managing blood pressure in acute cerebral infarction	15
Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?	15
Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis	15